Molecular point-of-care testing versus conventional RT-PCR for influenza A: Diagnostic performance, clinical decision-making, and costs in a tertiary hospital in Shenzhen, China

Feidi Ye, Qiaoruo Jin, Houming Liu, Yunjian Ma, Sheng Yu, Yang Yang, Jiuxin Qu

Open source

DOI
10.1016/j.jcv.2026.106005
Published
2026-12
Container
Journal of Clinical Virology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jcv.2026.106005,
  title = {Molecular point-of-care testing versus conventional RT-PCR for influenza A: Diagnostic performance, clinical decision-making, and costs in a tertiary hospital in Shenzhen, China},
  author = {Feidi Ye and Qiaoruo Jin and Houming Liu and Yunjian Ma and Sheng Yu and Yang Yang and Jiuxin Qu},
  year = {2026},
  journal = {Journal of Clinical Virology},
  doi = {10.1016/j.jcv.2026.106005},
  url = {https://doi.org/10.1016/j.jcv.2026.106005}
}

RIS

TY  - JOUR
TI  - Molecular point-of-care testing versus conventional RT-PCR for influenza A: Diagnostic performance, clinical decision-making, and costs in a tertiary hospital in Shenzhen, China
AU  - Feidi Ye
AU  - Qiaoruo Jin
AU  - Houming Liu
AU  - Yunjian Ma
AU  - Sheng Yu
AU  - Yang Yang
AU  - Jiuxin Qu
PY  - 2026
JO  - Journal of Clinical Virology
DO  - 10.1016/j.jcv.2026.106005
UR  - https://doi.org/10.1016/j.jcv.2026.106005
ER  - 

APA

Ye, F., Jin, Q., Liu, H., Ma, Y., Yu, S., Yang, Y., & Qu, J. (2026). Molecular point-of-care testing versus conventional RT-PCR for influenza A: Diagnostic performance, clinical decision-making, and costs in a tertiary hospital in Shenzhen, China. Journal of Clinical Virology. https://doi.org/10.1016/j.jcv.2026.106005

Source records